TGS NOPEC Geophysical Company ASA (TGS)
Oslo Børs · Norway · prices in NOK · close of 27 Oct 2026
Key indicators
| Last close | NOK 144.10 |
|---|---|
| 52-week range | 83.95 – 159.90 |
| Return, 1 month / 3 months | +0.3% / +11.3% |
| Return, 1 year / 3 years | +73.7% / +15.9% |
| Trend | Uptrend |
| RSI (14) | 58 |
| Volatility (1 year) | 39.6% |
| Worst drawdown (1 year) | -20.9% |
| Average daily value traded | 54.80M NOK |
| Dividend yield | 4.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
TGS NOPEC Geophysical Company is a geoscience data company based in Norway that serves the oil and gas industry. It gathers, processes and licenses seismic and other geophysical data from offshore basins around the world, building large libraries of subsurface information. Oil and gas exploration and production companies use this data to study rock formations beneath the seabed and to plan where to explore and drill. TGS also offers related services such as data processing, imaging and interpretation for its clients.
On this site TGS NOPEC Geophysical Company ASA appears as a stock on the Oslo Børs (Norway), code TGS, with prices in Norwegian kroner (NOK). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
TGS NOPEC Geophysical Company ASA (TGS) trades on the Oslo Børs in Norway. It last closed at NOK 144.10 on 27 October 2026.
Its price-based Market X-Ray is 69 out of 100 (a fair price profile), ranking 58 of 294 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 73.7% and over the last three months it rose 11.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Oslo Børs
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 73 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 11.7% | ||
| From 52-week high | -9.4% | ||
| Momentum | 72 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 11.3% | ||
| 6-month return | -0.6% | ||
| 12-month return, skipping the last month | 73.1% | ||
| Stability (higher is calmer) | 55 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 39.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -20.9% | ||
| Liquidity | 88 · Strong | Trades actively. | |
| Average daily value traded | 54.80M NOK | ||
| Zero-volume days | 0.0% | ||
| Income | 59 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 4.1% | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +4.7% |
|---|---|
| 1 month | +0.3% |
| 3 months | +11.3% |
| 6 months | −0.6% |
| 1 year | +73.7% |
| 3 years | +15.9% |
| 5 years | +128.4% |
Signals
| 50-day / 200-day average | 138.31 / 129.04 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 5.24 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 30 Jul 2026 | NOK 1.4900 |
| 8 May 2026 | NOK 1.4400 |
| 19 Feb 2026 | NOK 1.4700 |
| 30 Oct 2025 | NOK 1.5600 |
| 24 Jul 2025 | NOK 1.5800 |
| 16 May 2025 | NOK 1.5900 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Oslo Børs; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.